18 min listen
Can WeightWatchers survive the Wegovy era?
FromBehind the Money
ratings:
Length:
17 minutes
Released:
Apr 10, 2024
Format:
Podcast episode
Description
WeightWatchers is struggling. Launched in the early 1960s, the brand grew by helping members shed pounds through behavioural change programmes. Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded. FT reporter Anna Mutoh examines whether WeightWatchers’ latest strategy can produce the turnaround investors are hoping for. Clip from Lionsgate Television- - - - - - - - - - - - - - - - - - - - - - - - - - For further reading:WeightWatchers faces an era when weight loss comes in a syringeBehold the Ozempic effect on business The race to develop the next generation of weight-loss drugs- - - - - - - - - - - - - - - - - - - - - - - - - - On X, follow Anna Mutoh (@anna_mutoh) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more. Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
Released:
Apr 10, 2024
Format:
Podcast episode
Titles in the series (100)
How beauty is beating the rest of retail: Record numbers of bankruptcies and store closures have devastated the retail sector. So why is the beauty market thriving? Will the likes of Sephora and Ulta be able to ward off Amazon? With guests Moj Mahdara, chief executive of Beautycon, and&nbs... by Behind the Money